Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Protara Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 38 | +3 |
| Shares | 6.31M | 36.5K | 6.87M | +597.3K (+9.5%) |
| Value | $43.7M | $252.0K | $46.5M | +$3.07M (+7.1%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Protara Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DLD Asset Management, LP | 229,231 | $1.55M | 0.13% |
| Dimensional Fund Advisors LP | 33,474 | $226.0K | 0.00% |
| Sender Co & Partners, Inc. | 28,502 | $192.0K | 0.12% |
| Acadian Asset Management LLC | 17,219 | $115.0K | 0.00% |
| Gyon Technologies Capital Management, LP | 12,553 | $85.0K | 0.02% |
| Tower Research Capital LLC (TRC) | 799 | $6.00K | 0.00% |
| Federated Hermes, Inc. | 130 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Protara Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 23,955 | $166.0K |
| Virtu Financial LLC | 17,130 | $119.0K |
| Marshall Wace, LLP | 15,190 | $105.0K |
| Jump Financial, LLC | 14,500 | $100.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Protara Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 36,479 | $252.0K |